Medicare Part D coverage · 0.45 · RxCUI 1544396
0.45 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo]
Per the CMS 2026 Part D formulary file, 0.45 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] is covered by 311 Medicare Part D plans (6.2% of enrollable products), averaging Tier 3.1, with prior authorization required on 4.8% of covering formularies.
- 6.2%
- Plan coverage
- 311
- Plans covering
- T3.1
- Avg tier
- 4.8%
- Prior auth required
What the CMS Formulary Data Shows for 0.45 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo]
Per the CMS 2026 Part D formulary file, 0.45 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] (RxNorm concept RXCUI 1544396, generic name 0.45) appears on 63 distinct formulary files spanning 311 Medicare Part D plan offerings - 6.2% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.1.
Real-world access to 0.45 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] depends on utilization management as much as tier placement: 4.8% of covering formularies require prior authorization. 79.4% require step therapy. 3.2% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 5,262 Part D beneficiaries filled 0.45 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] in 2023, with total plan-and-beneficiary spending of $20,891,563 and an average per-beneficiary annual cost of $3,970.27. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 0.45 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] today.
Coverage Details
- Formularies covering
- 63
- Plans covering
- 311
- Coverage rate
- 6.2%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 4.8% of formularies
- Step therapy required
- 79.4% of formularies
- Quantity limits
- 3.2% of formularies
2023 Medicare Spending
- Beneficiaries
- 5,262
- Total spending
- $20,891,563
- Avg per beneficiary
- $3,970.27
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 0.45 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Elevate Medicare Choice (HMO D-SNP) | Denver Health Medical Plan, Inc. | T1 | No | $0 | CO |
| AllCare Advantage Redwood Rx (HMO D-SNP) | Allcare Health Plan, Inc. | T1 | No | $0 | OR |
| PrimeWest Senior Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | No | $0 | MN |
| Prime Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | No | $0 | MN |
| Alterwood Advantage Dual Secure (HMO D-SNP) | Alterwood Advantage, Inc. | T1 | No | $0 | MD |
| Nascentia Dual Advantage (HMO D-SNP) | Visiting Nurse Association OF Central NEW York | T1 | No | $0 | NY |
| Abilis Health Community (HMO I-SNP) | Signature Advantage, LLC | T1 | No | $0 | KY, TN |
| Arkansas Integrated Providers (AIP) Dual Advantage (HMO D-SNP) | Arkansas Superior Select, Inc. | T1 | No | $0 | AR |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Florida Inc | T1 | No | $4.80 | FL |
| Texas Independence Health Plan, Inc. (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | No | $4.80 | TX |
| Texas Independence Community Plan (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | No | $4.80 | TX |
| Tribute Select (HMO-POS I-SNP) | Arkansas Superior Select, Inc. | T1 | No | $8.90 | AR |
| ATRIO Special Needs Plan (HMO D-SNP) | Atrio Health Plans | T1 | No | $10.50 | OR |
| ATRIO Special Needs Plan (HMO D-SNP) | Atrio Health Plans | T1 | No | $10.50 | OR |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Arizona | T1 | No | $17.00 | AZ |
| Alterwood Advantage Dual Value (HMO D-SNP) | Alterwood Advantage, Inc. | T1 | No | $31.20 | MD |
| Valor Health Plan (HMO I-SNP) | TSG Guard, Inc. | T1 | No | $31.40 | OH |
| WV Senior Advantage (HMO I-SNP) | West Virginia Senior Advantage, Inc. | T1 | No | $32.70 | WV |
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is 0.45 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] covered by Medicare Part D?
Yes, 0.45 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] is covered by 311 Medicare Part D plans (6.2% of all Part D formularies).
What tier is 0.45 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] on Medicare Part D plans?
0.45 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] averages Tier 3.1 across Part D plans, ranging from Tier 1 to Tier 4.
Does 0.45 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] require prior authorization?
4.8% of Part D formularies require prior authorization for 0.45 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo]. Step therapy: 79.4%. Quantity limits: 3.2%.
How much does Medicare spend on 0.45 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo]?
In 2023, total Medicare Part D spending on 0.45 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] was $20,891,563, covering 5,262 beneficiaries. The average spend per beneficiary was $3,970.27.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- aripiprazole 15 MG Disintegrating Oral Tablet T3.1
- isotretinoin 30 MG Oral Capsule [Amnesteem] T3.1
- Pulmonary Hypertension tadalafil 20 MG Oral Tablet [Alyq] T3.1
- 1250 MG testosterone 0.0162 MG/MG Topical Gel T3.1
- dextroamphetamine sulfate 5 MG Extended Release Oral Capsule T3.1
- 24 HR pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet T3.1
Similar prior-authorization rate
- 0.15 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] 4.8% PA
- 0.2 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] 4.8% PA
- 0.25 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] 4.8% PA
- 0.6 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] 4.8% PA
- ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Jinteli] 4.7% PA
- trimipramine 100 MG Oral Capsule 4.9% PA